Organization Profile
Crescendo Bioscience
Organization Overview
Crescendo Bioscience, Inc., a wholly-owned subsidiary of Myriad Genetics, Inc., is developing a broad range of quantitative, objective molecular tests to provide rheumatologists with deeper clinical insights to more effectively manage patients with autoimmune and inflammatory diseases. The company applies a comprehensive suite of molecular profiling technologies to discover biomarkers and develop diagnostics that help physicians with the diagnosis, prognosis, and treatment of disease. Crescendo is initially focused on rheumatoid arthritis (RA), a debilitating, chronic disease affecting over 1.5 million in the USA and more than 2 million in Europe. Crescendo plans to establish a long-term partnership with clinicians by providing comprehensive diagnostic, prognostic, staging, therapy selection and monitoring capabilities to improve outcomes throughout the continuum of care. All testing will be performed at our own specialized, CLIA-licensed laboratory.
Crescendo’s strategy includes deep investments in Heath IT that help improve patient-provider communication and patient management, and that enable both physicians and patients to obtain the most value through Vectra® DA testing. Crescendo’s solutions include the VectraView™ web portal, which allows physicians and their staff to track individual patient progress and their practice population over time, and the MyRA® mobile app, designed in close collaboration with patients to empower them to regularly track symptoms and progress at home and better communicate with their physicians about their condition.
Notable Products / Brands
Vectra DA, VectraView, MyRA